0.008
0.00 (0.0%)
0.00 (0.0%)
Upgrade to Real-Time
Market Closed
Low
0.0008
High
0.034
Best deals to access real time data! |
|
Small Cap Basic
Monthly Subscription
for only
|
|
Ultimate Trader (Monthly)
Monthly Subscription
for only
|
|
DDE w/Realtime (Monthly)
Monthly Subscription
for only
|
|
VAT not included
|
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Pathfinder Cell Therapy Inc (PK) | PFND | OTCMarkets | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded  |
|
|---|---|---|---|---|
| 0.00 | 0.0% | 0.008 | 16:22:55 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 0.008 | 0.008 |
| Bid Price | Ask Price | Spread | News | |
|---|---|---|---|---|
| 0.0011 | 0.034 | 0.0329 | - | - |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| - | 0 | $ 0.008 | USD |
Pathfinder Cell Therapy (PK) Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| $ 5.34M | 667.16M | - | $ - | $ - | - | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| 17.32k | $ - | 0.00% | - | - |
Pathfinder Cell Therapy (PK) News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical PFND Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 0.0089 | 0.0089 | 0.008 | 0.0087692 | 39,000 | -0.0009 | -10.11% |
| 1 Month | 0.012 | 0.012 | 0.0062 | 0.0081197 | 67,763 | -0.004 | -33.33% |
| 3 Months | 0.006 | 0.034 | 0.0041 | 0.0105321 | 93,502 | 0.002 | 33.33% |
| 6 Months | 0.0033 | 0.034 | 0.0017 | 0.0084345 | 73,236 | 0.0047 | 142.42% |
| 1 Year | 0.0016 | 0.034 | 0.0008 | 0.0061703 | 69,221 | 0.0064 | 400.0% |
| 3 Years | 0.0023 | 0.034 | 0.0008 | 0.0040787 | 71,011 | 0.0057 | 247.83% |
| 5 Years | 0.0021 | 0.034 | 0.0004 | 0.0033661 | 76,071 | 0.0059 | 280.95% |
Pathfinder Cell Therapy (PK) Description
| Pathfinder Cell Therapy is developing a novel cell-based therapy for the treatment of diabetes, renal disease, myocardial infarction, and other diseases characterized by organ-specific cell damage. Pathfinder has discovered a new mammalian cell type, which is able to stimulate damaged tissues to regenerate without the Pathfinder Cells ("PCs") themselves being incorporated into the new tissue. |
